nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

Yazar: Thomas, Michael, Spigel, David R, Jotte, Robert M, McCleod, Michael, Socinski, Mark A, Page, Ray D, Gressot, Laurent, Knoble, Jeanna, Juan, Oscar, Morgensztern, Daniel, Isla, Dolores, Kim, Edward S, West, Howard, Ko, Amy, Ong, Teng Jin, Trunova, Nataliya, Gridelli, Cesare
Yayımlandı Lung Cancer (Auckl) (2017)

A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small...

Yazar: Spigel, David R., Shipley, Dianna L., Waterhouse, David M., Jones, Suzanne F., Ward, Patrick J., Shih, Kent C., Hemphill, Brian, McCleod, Michael, Whorf, Robert C., Page, Ray D., Stilwill, Joseph, Mekhail, Tarek, Jacobs, Cindy, Burris, Howard A., Hainsworth, John D.
Yayımlandı Oncologist (2019)

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell...

Yazar: Salgia, Ravi, Weaver, R. Waide, McCleod, Michael, Stille, John R., Yan, S. Betty, Roberson, Stephanie, Polzer, John, Flynt, Amy, Raddad, Eyas, Peek, Victoria L., Wijayawardana, Sameera R., Um, Suzane L., Gross, Steve, Connelly, Mark C., Morano, Carrie, Repollet, Madeline, Sanders, Renouard, Baeten, Kurt, D’Haese, David, Spigel, David R.
Yayımlandı Invest New Drugs (2017)

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153

Yazar: Waterhouse, David M., Garon, Edward B., Chandler, Jason, McCleod, Michael, Hussein, Maen, Jotte, Robert, Horn, Leora, Daniel, Davey B., Keogh, George, Creelan, Ben, Einhorn, Lawrence H., Baker, Justin, Kasbari, Samer, Nikolinakos, Petros, Babu, Sunil, Couture, Felix, Leighl, Natasha B., Reynolds, Craig, Blumenschein, George, Gunuganti, Vijay, Li, Ang, Aanur, Nivedita, Spigel, David R.
Yayımlandı J Clin Oncol (2020)